Your browser doesn't support javascript.
loading
Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization.
Cortese, Franco; Klokov, Dmitry; Osipov, Andreyan; Stefaniak, Jakub; Moskalev, Alexey; Schastnaya, Jane; Cantor, Charles; Aliper, Alexander; Mamoshina, Polina; Ushakov, Igor; Sapetsky, Alex; Vanhaelen, Quentin; Alchinova, Irina; Karganov, Mikhail; Kovalchuk, Olga; Wilkins, Ruth; Shtemberg, Andrey; Moreels, Marjan; Baatout, Sarah; Izumchenko, Evgeny; de Magalhães, João Pedro; Artemov, Artem V; Costes, Sylvain V; Beheshti, Afshin; Mao, Xiao Wen; Pecaut, Michael J; Kaminskiy, Dmitry; Ozerov, Ivan V; Scheibye-Knudsen, Morten; Zhavoronkov, Alex.
Afiliação
  • Cortese F; Biogerontology Research Foundation, London, UK.
  • Klokov D; Department of Biomedical and Molecular Sciences, Queen's University School of Medicine, Queen's University, Kingston, Ontario, Canada.
  • Osipov A; Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.
  • Stefaniak J; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Moskalev A; Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University, Baltimore, MD, USA.
  • Schastnaya J; State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russia.
  • Cantor C; Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
  • Aliper A; Biogerontology Research Foundation, London, UK.
  • Mamoshina P; Nuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford, UK.
  • Ushakov I; Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
  • Sapetsky A; Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of Russian Academy of Sciences, Syktyvkar, Russia.
  • Vanhaelen Q; Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, Russia.
  • Alchinova I; Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University, Baltimore, MD, USA.
  • Karganov M; Boston University, Department of Biomedical Engineering, Boston, MA, USA.
  • Kovalchuk O; Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University, Baltimore, MD, USA.
  • Wilkins R; Laboratory of Bioinformatics, D. Rogachev Federal Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Shtemberg A; Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University, Baltimore, MD, USA.
  • Moreels M; Computer Science Department, University of Oxford, Oxford, UK.
  • Baatout S; State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russia.
  • Izumchenko E; State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russia.
  • de Magalhães JP; Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University, Baltimore, MD, USA.
  • Artemov AV; Laboratory of Physicochemical and Ecological Pathophysiology, Institute of General Pathology and Pathophysiology, Moscow, Russia.
  • Costes SV; Research Institute for Space Medicine, Federal Medical Biological Agency, Moscow, Russia.
  • Beheshti A; Laboratory of Physicochemical and Ecological Pathophysiology, Institute of General Pathology and Pathophysiology, Moscow, Russia.
  • Mao XW; Canada Cancer and Aging Research Laboratories, Ltd., Lethbridge, Alberta, Canada.
  • Pecaut MJ; University of Lethbridge, Lethbridge, Alberta, Canada.
  • Kaminskiy D; Environmental and Radiation and Health Sciences Directorate, Health Canada, Ottawa, Ontario, Canada.
  • Ozerov IV; Laboratory of Extreme Physiology, Institute of Medical and Biological Problems RAS, Moscow, Russia.
  • Scheibye-Knudsen M; Radiobiology Unit, Interdisciplinary Biosciences, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre, (SCK·CEN), Mol, Belgium.
  • Zhavoronkov A; Radiobiology Unit, Interdisciplinary Biosciences, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre, (SCK·CEN), Mol, Belgium.
Oncotarget ; 9(18): 14692-14722, 2018 Mar 06.
Article em En | MEDLINE | ID: mdl-29581875
ABSTRACT
While many efforts have been made to pave the way toward human space colonization, little consideration has been given to the methods of protecting spacefarers against harsh cosmic and local radioactive environments and the high costs associated with protection from the deleterious physiological effects of exposure to high-Linear energy transfer (high-LET) radiation. Herein, we lay the foundations of a roadmap toward enhancing human radioresistance for the purposes of deep space colonization and exploration. We outline future research directions toward the goal of enhancing human radioresistance, including upregulation of endogenous repair and radioprotective mechanisms, possible leeways into gene therapy in order to enhance radioresistance via the translation of exogenous and engineered DNA repair and radioprotective mechanisms, the substitution of organic molecules with fortified isoforms, and methods of slowing metabolic activity while preserving cognitive function. We conclude by presenting the known associations between radioresistance and longevity, and articulating the position that enhancing human radioresistance is likely to extend the healthspan of human spacefarers as well.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article